Tweedy Browne Co. Abb Vie Inc. Transaction History

Tweedy, Browne CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $41.5 Million - $47.1 Million	-390,370 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $128,882 - $143,582	-1,225 Reduced 0.31%	390,370 $44 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $65,472 - $72,076	-640 Reduced 0.16%	391,595 $42.4 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $7.24 Million - $9.77 Million	89,915 Added 29.74%	392,235 $42 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $8.27 Million - $9.71 Million	96,320 Added 46.76%	302,320 $26.5 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $15.1 Million - $20.2 Million	206,000 New	206,000 $20.2 Million

3,694

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Tweedy, Browne CO LLC, based on Form 13F filings with the SEC.

Stay updated on Tweedy, Browne CO LLC and Tweedy Browne Co. with notifications on news.